Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study. (Q33373325)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study. |
scientific article |
Statements
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study (English)
Hervé Rubie
Julia Chisholm
Bruce Morland
Caroline Munzer
Véronique Mosseri
Christophe Bergeron
Clare Weston
Carole Coze
Anne Auvrignon
Latifa Djafari
Rachel Hobson
Christiane Baunin
Fiona Dickinson
Kieran McHugh
Lorenzo Biassoni
Francesco Giammarile
Gilles Vassal
Société Françaisedes Cancers de l'Enfant
United Kingdom Children Cancer Study Group-New Agents Group Study
Dominique Valteau-Couanet
1 November 2006